The importance of nitric oxide (NO) during focal cerebral ischemia remains controversial as studies have suggested both a neurotoxic and neuroprotective role. In the 7 d old rat pup, NJ -nitro-L-arginine, a nitric oxide synthase inhibitor, reduced infarct volume in a model of unilateral carotid ligation with 2.5 h exposure to 8% O 2 , The current study examined whether NO is neurotoxic in a filament model of transient middle cerebral artery occlusion (MCAO) in the 14-1 8-d-old rat pup. We developed a reproducible filament model of transient MCAO in 14-18-d-old spontaneously hypertensive rats (35 g) by passing a no. 6-0 (0.07-mm) nylon filament via the carotid artery to occlude the middle cerebral artery for 4 h under normoxic conditions. After filament removal and reperfusion for 24 h, we determined infarct volume using the mitochondrial stain 2,3,5-triphenyltetrazolium chloride. NO synthesis was inhibited using NJ -nitro-iarginine methyl ester (L-NAME) at a dose of 3 mg/kg, intraperitoneally, 1 h before MCAO. We measured infarct volume in control (n = 7) and L-NAME (n = 7) groups. L-NAME reduced infarct volume by 55% (p < 0.01). In the control group, infarct Hypoxic-ischemic injury of the nervous system has been attributed, in part , to the neuronal release of excitato ry amino acids . Recent studies suggest that this typ e of injury involv es glutama te-induce d neurotoxicit y w hich migh t, to som e degree, be medi ated by NO (1-3). However, the rol e of NO rem ain s controversial as there are now more than a dozen studies since 1991 w hich suggest eithe r a neurotoxic or neuroprotecti ve ro le of NO during isch emia (4 -7) . End oth elial NO release during isch em ia mi ght be beneficial by increasing CBF; altern ati vely, neuronal NO release during ischemia or reperfusion migh t be neurotoxic.
The importance of nitric oxide (NO) during focal cerebral ischemia remains controversial as studies have suggested both a neurotoxic and neuroprotective role. In the 7 d old rat pup, NJ -nitro-L-arginine, a nitric oxide synthase inhibitor, reduced infarct volume in a model of unilateral carotid ligation with 2.5 h exposure to 8% O 2 , The current study examined whether NO is neurotoxic in a filament model of transient middle cerebral artery occlusion (MCAO) in the 14-1 8-d-old rat pup. We developed a reproducible filament model of transient MCAO in 14-18-d-old spontaneously hypertensive rats (35 g ) by passing a no. 6-0 (0.07-mm) nylon filament via the carotid artery to occlude the middle cerebral artery for 4 h under normoxic conditions. After filament removal and reperfusion for 24 h, we determined infarct volume using the mitochondrial stain 2,3,5-triphenyltetrazolium chloride. NO synthesis was inhibited using NJ -nitro-iarginine methyl ester (L-NAME) at a dose of 3 mg/kg, intraperitoneally, 1 h before MCAO. We measured infarct volume in control (n = 7) and L-NAME (n = 7) groups. L-NAME reduced infarct volume by 55% (p < 0.01). In the control group, infarct Hypoxic-ischemic injury of the nervous system has been attributed, in part , to the neuronal release of excitato ry amino acids . Recent studies suggest that this typ e of injury involv es glutama te-induce d neurotoxicit y w hich migh t, to som e degree, be medi ated by NO (1) (2) (3) . However, the rol e of NO rem ain s controversial as there are now more than a dozen studies since 1991 w hich suggest eithe r a neurotoxic or neuroprotecti ve ro le of NO during isch emia (4 -7) . End oth elial NO release during isch em ia mi ght be beneficial by increasing CBF; altern ati vely, neuronal NO release during ischemia or reperfusion migh t be neurotoxic.
The role of hypo xic-i sch emi c excitotoxic neon atal ce rebra l injury has also received increasing attention. Dem onstration of the rol e of glutamate relea se and NMDA receptor ac tiva tion ). In the L-NAME-treated group, infarct volume (77 ::' ::: 19 mrrr') was 22 ::' ::: 5% of the left hemispheric volume (344 ::' ::: 2 mm' ). These findings support earlier studies that used models of neonatal hypoxic-ischemic brain injury and suggest a neurotoxic role of NO. They extend these observations by demonstrating a significant reduction in infarct volume in a stroke model in the immature rat pup. (Pediatr Res 38: 652-656 ,  1995) Abbreviations CBF , cerebral blood flow L-NAME, NJ -nitro-L-arginine methyl ester MCAO, middle cerebral artery occlusion NO, nitric oxide NOS, NO synthase SHR, spontaneously hypertensive rat TTC , 2,3,5-triphenyitetrazolium chloride NMDA, N-methyl-D-aspartic acid during injury is now well est ablished (8) . Of interest is the observatio n that neon at al hyp oxic-isch emic injury selecti vely spa res NADPH-diaphorase -staining neurons that have bee n shown in ad ult mod els to synt hes ize NO (2, 9) . In 7-d-old rat pups, inh ibition of NOS with W -nitro-L-arg inine (50 -100 mg/kg) reduced hemispheric we ight disp arity in a model of left co mmon ca rotid ligation with 8% 0 2 and suggests that NO was neur oto xic (10) . More rece ntly, Ham ada et al. (12) fou nd a 77 % reduction in cor tica l and an 88 % reduct ion in striatal infarct vo lume using a similar model (tfJ -nit ro-r-arginine, 2 mg/kg int raperitoneally) in 7-d-old rat pups with infarct volum e det erm ined by hemot oxylin and eosin stain ing .
We developed a reproducible transie nt MCAO stroke mod el in 14-18-d-old SI-IR pups and in the present study examined wh ether low do se NO inh ibition with L-NA ME (N G-nitro-Larginine methyl es ter) affects cerebral infarct volume . We developed this mod el to reflect the physiologic events that occur during stro ke du e to ce rebrovascular occlusio n (11) .
L-NAME REDUCES INFARCT VOLUME IN THE RAT PUP 653 With this filament model of MCAO there is minimal surgical trauma resulting in better preservation of cerebrovascular and endothelial function in contrast to doing a craniotomy that involves temporary surgical ligation of the middle cerebral artery, a procedure that is quite difficult. We used L-NAME, a nonspecific endothelial and neuronal NOS inhibitor administered intraperitoneally in low doses (3.0 mg/kg) 1 h before the onset of 4-h MCAO and 24-h reperfusion because our previous studies demonstr ated that this dose reduced infarct volume in the adult SHR by 55% (13) . Although the 14-18-d-old rat pup model of transient MCAO may not be considered a true neonat al model, it is a model involving the immature brain that reflects changes occurring with development.
METHODS
Surgical preparation. We used 14-18-d-old SHR pups (n = 14) whose weight averaged 35 g. In our previous studies we used adult SHR (weight = 400 g) becau se we have been able to create an extremely reproducibl e infarct using either a craniectom y (3 h MCAO and· 2 h reperfusion) or a filament model (2 h MCAO and 24 h reperfusion) (13, 14) . In preliminary studies, we were able to produc e a reliable infarct in these pups but animal size limitations preclud ed doing these studies in young er animals (11, 15) .
SHR pups were anesthetiz ed with 2% isoflurane (Forane) by mask and allowed to breathe spontaneously. End tidal isoflurane concentration (1.2%) was determ ined with a PuritanBennett Datex Capnom ac infrared anesthet ic gas analyzer as previously reported (16, 17) . Body temperature was maintained at 37°C throughout the experimental procedure, and the rat pups were maintain ed during the 24-h period of reperfusion in a temperature-controlled environment at 95-100°F. The temperatures were recheck ed at 24 h and were similar in both control and experimental groups.
Establishment of reversible focal cerebral ischemia. SHR pups were placed in the supine position on the platform of a Zeiss stereosco pic microscope (model #OMPl), and the left common carotid artery was exposed. The left extern al carotid artery was isolated and ligated. A tie was loosely placed around the intern al carotid artery to control backflow, and a vascular clamp was placed on the common carotid artery 1 em proximal to the bifurc ation. A small incision was made in the external carotid artery close to the ligature and a no. 6-0 (0.07 mm) nylon filament passed proximally into the internal carotid artery to transiently occlud e the middle cerebral artery. The filament was then sutur ed in place, the clamp on the common carotid artery removed, and the skin closed with 3-0 silk. The duration of this procedur e was 20 min. The pups were allowed to recover from anesthesia and were returned to their litters and maintained in a normoxic environment for 4 h. After this period of normoxic MCAO , the pups were reanesthetized, the filament carefully removed, the external caro tid artery ligated, and the wound closed. The pups were then returned to their litters for 24 h after which time they were killed so that infarct volumes could be determin ed.
Effect of L-NAME on cerebral infarct volume. We examined whether L-NAME (3 mg/kg, intraperitoneally; 11 = 7)
given 60 min before 4-h MCAO and 24-h reperfusion reduced infarct volume comp ared with control animals (n = 7) given an equal volume of Ringer's lactate solution. The dose of L-NAME and time period were chosen to ensure that the inhibitory effects of L-NAME on vascul ar and parench ymal NO synth esis were optimal during the period of occlusion and were based on previou s pharmacok inetic studies that showed that the onset of the L-NAME effect begins within 30 min of infusion (18, 19) .
Measurement of infarct volume.
Neurop athologic evaluation of brain injury was accompl ished using the histochemic al stain TIC as previously reported by us and other investig ators (13, (20) (21) (22) (23) (24) . In normal brain, TIC is converted by mitochondrial oxidative enzyme s to a red-fo rmazan product, resulting in a deep red staining of brain parenchyma. Prolonged ischemia renders mitochondrial enzymes dysfuncti onal and causes failure of TIC conversion, result ing in a pale area in the brain . Several recent studies have show n good correlation in the measurement of infarct volume using TIC or conventional neuropathology at 24 h in the rat MCAO model (22, 23) .
At the end of the 24-h reperfusion period , the pups were placed in an induction chamb er, deeply anesthetized with 4.0 -4.5% Forane, after which a 24 gauge catheter (Insyte, Becton Dickinson) was inserted into the left ventr icle, and a 2% TIC solution prewarmed to 3rC in isotonic saline was infused (4 ml.zrnin) for 8 min with effl uent released through an incision in the right atrium. An additional 10 min for staining was allowed befor e fixation with a 10% buffered formalin/l0% gluteraldehyde solution (1:1) using the same rate and volume of infusion. The brain was then removed, embedded in an egg albumin:gelatin medium , and mount ed on a vibratome (Vibratome Series 1000; Technical Products Intern ation al Inc., St. Louis, MO). Serial slices in 1.0-mm increments spanning the area of middle cerebral artery distribution were cut, and seven stand ardized coron al brain sections were select ed and photographed with color slide film (Ektachrome, Tungsten 160 ASA). The photo graphs we re analyze d usin g a Drexel! DUMAS Image Processing System and the area of deficient TIC staining determined manu ally by an observer blind ed to treatment assignment. For each section, the volume of deficient stain ing and the volume of the entire hemisphere were determined, and a percent infarct volume was calcul ated. To estimate the percent infarct volume for the entire hemisphere, the infarct volumes and total hemisphere volumes were separately added, and the ratio was calculat ed. Because edem a may alter the measurement of infarct volum e, we corrected for this by using the previously published method of Swanson et at. (25) .
Data analysis. The percent volume of infarction in control and L-NAME-treated animals was compared using a factorial one-way analysis of variance with two independ ent groups.
Comparison of the seven sectional infarct volum es between control and L-NAME groups were analyzed with a repeated measures two-way analysis of vari ance. Throughout the text, results are given as the mean ± the SEM, and 11 refers to the number of animals. Unless otherw ise specified, statistical significance was assumed at the p < ). In the L-NAME-treated gro up (n = 7; weig ht = 35.5 :±: 1.4 g), infarct volume (77 :±: 19 mrrr') was 22 :±: 5% of the left hemispheric volume (344 :±: 2 mrrr'). In addition, the left hemisphere volume in the control group was 4.6% greater than that observed in the L-NAME group and provides additional supportive data that L-NAME reduced neurotoxicity. In Figure 1 a representative section of a contro l and L-NAME section are show n, demonstrating the volume of mitochondrial pallor that reflects focal ischemic injury. Figure  2 depicts the seven serial cross-sections from the SHR pup brain with the black shaded area indicating the mean volume of infarction for that section. Significant differences were observed between control and L-NAME groups for sections two to seve n (0.009 < P > 0.03; p value for section one = 0.12). The prese nt study demonstrates that inhibition of NOS using low dose L-NAME reduced infarct volume in a filament model of transient MCAO in the 14-18-d-old rat pup. These findings support previous studies that have sugges ted that NO may be neurotoxic in the deve loping nervous system (10, 12) .
NO and models offo cal cerebral ischemia . Stud ies examining the role of NO during focal cerebral ischemia have been difficult to interpret as the results have been conflicting (4 -7) . As yet, no unifying theory has been proposed that can reconcile these contradictory findings with the dual nature of NO as both a vasodilator and neurotoxin. Experimental variables such as the model used to create ischemia (permanent versus focal), the dose and specific NOS inhibitor administered, and the durati on of MCAO and reperfusion have all affected the results and thus the interpretation of the role of NO. Studies by several investigators have suggested that NO release during ischemia might increa se CBF (4, 5) . Our recent studies (13) as well as those of Huang et al. (26) have provided convincing evidence that although NO release during focal ischemia is likely to increase CBF and potentially reduce infarct volume, the overall effect of NO is that of serious neurotoxicity.
Glutamate and NO neurotoxicity in the newborn. Ther e is substantial evidence that glutamate toxicity may be important in the developing brain (8, 27, 28) . Marked elevation of extracellular glutamate and aspartate occur in the striatum and cortex during fetal lamb asphyxia and parallel the sever ity of asphyxia in a neonatal rat model of focal cerebral ischemia (29, 30) . In addition, the neuropathologic progression after hypoxic-ischemic injury in the neonate is indistinguish able from that due to excitotoxic damage due to glutamate administration (31) . It has also been shown that MK-801, a NMDA receptor antagonist, can block hypoxic-ischemic injury in the neonatal rat (28) .
As glutamate and other excitatory neurotransmitters are suspected of playing a role in the neurotoxicity associated with hypoxic-ischemic brain injury, it has been sugges ted that NO might be one of the agents that mediates this response (1, 2) . NO is formed in response to NMDA receptor activation by excitatory neurotransmitters such as glutamate (32) . NOS inhibitors decrease brain NO produ ction and also prevent NMDA neuronal toxicity in rat cortex, caudate-putamen, and hippocampal cell culture studies as well as in vitro in the hippocampal slice preparat ion and in vivo in the hippocampus (2, (33) (34) (35) . Finally, NOS inhib ition with L-NAME, has been shown to reduce infarct volume produced by NMDA receptor activation by 35% (36) .
The relation between glutamate neurotoxicity and NO durina development remains complex. Each of the glutamate b . .
receptor subtypes possess unique development al neurotoxicit y profiles (37) . In the 7-d-old rat pup glutamate neurotox icity is mediated primarily by NMDA and quisqualatela-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor activation in contrast to the adult rat where kainate is more neurotoxic. Moreover, glutama te susceptibility in different brain regions and neuronal populations changes significantly with development. In addition, both cytosolic and particulate forms 24 (7) 49 (8) 27 (5) 54 (8) 25 (6) 51 (6) 44 (6) 19 (5) 22 (7) 45 (4) 20 (6) 46 (9) 18 (7) 38 (10) Figure 2 . Seve n representative cross-sections fro m the brain of control (n = 7) and L-NAME-treated (n = 7) groups are depicted from anterior (left; section one) to posterior (right; section seven). The darkened areas represent the mean perce nt volume of infarction for that group at that particular cross -sectional level. The distribution of infarct that is outlined was based on the result s of our determination of the areas of infarction for each sectional level. Th e mean ( ::': SEM) percent volum e of infarction are given under each section. L-NAME significantly reduced infarct volum e in sections two to seven (0.009 < p > 0.03; p value for section one = 0.12).
of NOS change with development (38, 39) . In rat cerebrum , particul ate NOS increases in the first postnatal week , then decre ases and becomes almost undetectable in the adult. In contra st, cytosolic NOS increases somewhat in the rat cerebrum and about 8-fold in the cerebellum over the same time frame. Irrespective of these complex developmental changes, the fact that NOS inhibition reduced infarct volumes in 7-(12) and 14-18-d-old rat pups (current study) suggests a relation betwe en focal ischemic injury, NO synthesis and neurotoxicity.
NO neurotoxicity during focal cerebral ischemia in the developing brain. Several mechanisms have been sugge sted to explain NO-mediated neuroto xicity includin g free radical induced damage to protein s, DNA, and membrane lipids; direct inactivation of enzymes involved in mitochondrial respiration ; and energy depletion subsequent to activation of poly-ADP ribose synthase after NO-dependent damage (7) . The relative contributions of any of these mechani sms in either focal or global neonatal hypoxic-i schemic injury have yet to be investigated . Of interest is the observation that NOS expression (and presum ably NO producti on) may play an important role in the regulation of axonal projections during development (40) . This may be of particular importance during focal cerebral ischemia as recent studi es have shown not only an increase in NO immediat ely after occlusion but a delayed more marked increase in NO producti on that peaks at 24 h and lasts for several days (41) . Thus, NO neurotoxicity could persist long after the insult and might have a subtle but definite impact on neuronal and glial development.
A new model ofstroke in the immature rat pup. The present study demonstrate s the feasibilit y of adapting an adult model of reversible MCAO without craniectomy to the rat pup. The desire to develop a reliabl e rat pup model of reversible focal ischemi a was based on the limitations of currently available models of foca l cerebr al ischemia in the newborn animal. The Rice-Vannucci model of unilate ral carotid ligation with 2-3 h of exposure to 8% O 2 has been used in the rat to examine a variety of questions related to the pathogenesis of neonatal hypoxic-i schemic injury (11, 42) . Althou gh, the lesion created with this model is unilateral, it is primaril y a model of a diffuse hypoxic-ischemic hemispheric insult rather than one due to focal occlusive cerebrovascular disease (e.g. neonatal stroke) as is the filament MCAO model.
Since 1986, several studies have been publish ed describing filament models of reversibl e MCAO without craniectomy in the adult rat (43) (44) (45) (46) . Infarct volum e (TIC) averaged 37.6 % with permanent MCAO and 21.9 % after 2 hand 25.7% after 4 h of reversible MCAO (45) . A more recent study found that CBF was reduced to near constant values at 20, 60, and 120 min of occlusion and averaged 10% of controls in the area of irreversible infarction and 15-20% in the penumbral region (46) . With 24-h permanent MCAO , infarct volume measured 70% in cortex and caudoputamen; with 1-h reversible MCAO infarct volume at 7 d measured 30-35%.
The volume of infarct involving cortical as well as caudoputamenal regions that we observed in our 14-18-d-old rat pup model is similar to that noted in the above studies . Developing a newborn model of reversible MCAO without craniectomy was technically challenging. In contrast to adult rats that weighed 350-400 g, 14-18-d-old rat pups average 35 g. The filament diameter and length are substantially smaller than that used in adults. In these animals it is also difficult to cannulate the femoral artery for measur ement of different physiologic variables or the femoral vein for drug infusions and intraperitoneal injections are usuall y necessary.
A limitation of this filament model is the age of the rat pups when a stroke can reliably be created. Unilateral carotid ligation with 8% O 2 can be accompli shed in the rat pup after 7 d of age (42) . In the filament model of MCAO without craniectomy, size limitations preclude performing this procedure before 14 d (35 g). Thus, there are limitations in considering this a model of neonatal stroke as many biochemical, physiologic, and anatomical changes occur in the rat pup between d 7 and d 14-18 (38, 39) . These two models of cerebro vascular injury (i.e. unilateral carotid ligation with 8% O 2 versus normo xic filament MCAO), however, can be considered complementary as they examine two different types of cerebr al insults (hypoxic-ischemic injury versus stroke) that occur in the neonatal period. The clinic al relevance for developing a model of neonatal stroke has become apparent over the past decade as neuroimaging studies have convincingly demonstrated that 656 iNAN ET AL. such lesions are more common than previously recognized and account for serious neurologic morbidity. Although the incidence is uncertain, recent studies have suggested that neonatal stroke accounts for up to 20% of patients with neonatal seizures, and other investigators have found a 5% incidence of neonatal stroke at autopsy (47) .
CONCLUSIONS
L-NAME reduced infarct volume by 55% in a filament model of transient focal cerebral ischemia in the SHR pup. These findings are similar in magnitude to that which we observed in the adult SHR using the same dose of L-NAME (13). They also support earlier studies that used models of neonatal hypoxic-ischemic brain injury and suggest a neurotoxic role for NO in the developing nervous system.
